Michelle D. Wiest

450 total citations
12 papers, 351 citations indexed

About

Michelle D. Wiest is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and Immunology. According to data from OpenAlex, Michelle D. Wiest has authored 12 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Economics and Econometrics, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Immunology. Recurrent topics in Michelle D. Wiest's work include Pharmaceutical Economics and Policy (6 papers), Biosimilars and Bioanalytical Methods (5 papers) and Pharmaceutical studies and practices (5 papers). Michelle D. Wiest is often cited by papers focused on Pharmaceutical Economics and Policy (6 papers), Biosimilars and Bioanalytical Methods (5 papers) and Pharmaceutical studies and practices (5 papers). Michelle D. Wiest collaborates with scholars based in United States and Canada. Michelle D. Wiest's co-authors include Linda M. Matusiak, Katie J. Suda, Glen T. Schumock, JoAnn Stubbings, Robert J. Hunkler, Lee C. Vermeulen, Edward C. Li, Sandra Cuéllar, Matthew H Rim and Mina Tadrous and has published in prestigious journals such as American Journal of Health-System Pharmacy.

In The Last Decade

Michelle D. Wiest

12 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle D. Wiest United States	10	142	80	75	50	38	12	351
JoAnn Stubbings United States	12	224 1.6×	134 1.7×	99 1.3×	118 2.4×	48 1.3×	28	492
Binaya Sapkota Nepal	13	105 0.7×	90 1.1×	60 0.8×	45 0.9×	17 0.4×	54	523
J. Russell May United States	9	100 0.7×	158 2.0×	100 1.3×	19 0.4×	24 0.6×	25	425
Olga Delgado Sánchez Spain	11	57 0.4×	166 2.1×	61 0.8×	54 1.1×	36 0.9×	56	440
Linda M. Matusiak United States	14	274 1.9×	84 1.1×	134 1.8×	73 1.5×	75 2.0×	20	627
Åsmund Reikvam Norway	13	63 0.4×	110 1.4×	41 0.5×	30 0.6×	44 1.2×	61	467
Anand Harugeri India	7	105 0.7×	209 2.6×	71 0.9×	58 1.2×	11 0.3×	10	406
Muhammed Rashid India	12	42 0.3×	81 1.0×	50 0.7×	31 0.6×	16 0.4×	61	395
Piera Polidori Italy	10	59 0.4×	74 0.9×	57 0.8×	15 0.3×	13 0.3×	38	370
Mirta Millares United States	7	142 1.0×	96 1.2×	90 1.2×	23 0.5×	19 0.5×	10	317

Countries citing papers authored by Michelle D. Wiest

Since Specialization

Citations

This map shows the geographic impact of Michelle D. Wiest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle D. Wiest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle D. Wiest more than expected).

Fields of papers citing papers by Michelle D. Wiest

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle D. Wiest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle D. Wiest. The network helps show where Michelle D. Wiest may publish in the future.

Co-authorship network of co-authors of Michelle D. Wiest

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle D. Wiest. A scholar is included among the top collaborators of Michelle D. Wiest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle D. Wiest. Michelle D. Wiest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

DiPiro, Joseph T., et al.. (2021). ASHP Foundation Pharmacy Forecast 2022: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems. American Journal of Health-System Pharmacy. 79(2). 23–51. 12 indexed citations

Tichy, Eric M., James M. Hoffman, Katie J. Suda, et al.. (2021). National trends in prescription drug expenditures and projections for 2021. American Journal of Health-System Pharmacy. 78(14). 1294–1308. 33 indexed citations

Tichy, Eric M., Glen T. Schumock, James M. Hoffman, et al.. (2020). National trends in prescription drug expenditures and projections for 2020. American Journal of Health-System Pharmacy. 77(15). 1213–1230. 38 indexed citations

Schumock, Glen T., JoAnn Stubbings, James M. Hoffman, et al.. (2019). National trends in prescription drug expenditures and projections for 2019. American Journal of Health-System Pharmacy. 76(15). 1105–1121. 28 indexed citations

Wiest, Michelle D., et al.. (2019). Improving efficiency of financial authorization by establishing a standard infusion workflow. American Journal of Health-System Pharmacy. 76(11). 780–783. 1 indexed citations

Schumock, Glen T., JoAnn Stubbings, Michelle D. Wiest, et al.. (2018). National trends in prescription drug expenditures and projections for 2018. American Journal of Health-System Pharmacy. 75(14). 1023–1038. 28 indexed citations

Schumock, Glen T., Edward C. Li, Michelle D. Wiest, et al.. (2017). National trends in prescription drug expenditures and projections for 2017. American Journal of Health-System Pharmacy. 74(15). 1158–1173. 42 indexed citations

Schumock, Glen T., Edward C. Li, Katie J. Suda, et al.. (2016). National trends in prescription drug expenditures and projections for 2016. American Journal of Health-System Pharmacy. 73(14). 1058–1075. 80 indexed citations

Schumock, Glen T., Edward C. Li, Katie J. Suda, et al.. (2015). National trends in prescription drug expenditures and projections for 2015. American Journal of Health-System Pharmacy. 72(9). 717–736. 31 indexed citations

10.

Polk, Ronald E., et al.. (2012). Antibiogram compliance in University HealthSystem Consortium participating hospitals with Clinical and Laboratory Standards Institute guidelines. American Journal of Health-System Pharmacy. 69(7). 598–606. 30 indexed citations

11.

Wiest, Michelle D., et al.. (2010). Implementation of intelligent infusion technology in a multihospital setting. American Journal of Health-System Pharmacy. 67(11). 878–883. 4 indexed citations

12.

Bush, Paul W., et al.. (2010). Pharmacy practice model for academic medical centers. American Journal of Health-System Pharmacy. 67(21). 1856–1861. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact